Share

Orthogonal has developed a number of FDA-cleared AI and machine learning algorithms, including solutions in cardiac monitoring, diabetes care, in vitro diagnostics and neuromodulation – and we’re involved in the ongoing development of AI-related standards. We’re experts at tuning and deploying models on a wide range of infrastructure, and have incorporated good machine learning practices for data management, model training, validation and more into our QMS.